by Max Verhage | Dec 9, 2025 | Uncategorized
You’ve spent years developing a promising compound as a professor, clinician, or researcher. The preclinical data looks solid. There’s clear potential to help patients with an unmet medical need. But now you face a tough question: how do you get your...
by Barbara Van den Aarsen | Nov 12, 2025 | Uncategorized
What is a Paediatric Investigation Plan (PIP)? The European Medicines Agency (EMA) requires sponsors to follow Paediatric Investigation Plan (PIP) guidelines as part of the regulatory process for developing medicines intended for children. While other regulatory...
